Dorrapharma is engaged in R&D, manufacture and market of intermediates, APIs (Active Pharmaceutical Ingredients) and formulations. We own the core technology advantage in the professional area of bromination, enzyme/metal-catalyzed,nitration and hydrogenation, and obtain multiple core patents for invention.We stick to raising the value both for the company and customers, and strive for serving for the society and caring of the others. We devote ourselves completely to the technology innovation and brand build and make every effort to foster the core competence for the company with the company mission of a leading integrated operator with its core competitive advantage in global pharmaceutical industry.